PCV – Pneumococcal Conjugate Vaccine

Protects against Streptococcus pneumoniae, a leading cause of pneumonia, meningitis, and ear infections in young children. PCV13 (Prevenar) covers 13 serotypes and is now part of India's UIP.

The PCV – Pneumococcal Conjugate Vaccine is recommended for 6 weeks, 10 weeks, 14 weeks (primary); 9 months (booster). It falls under the Childhood vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The PCV – Pneumococcal Conjugate Vaccine has an efficacy of 75–90%. This means it provides significant protection against Pneumococcal Pneumonia and Meningitis. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Mild fever; redness and swelling at injection site; drowsiness; loss of appetite. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The PCV – Pneumococcal Conjugate Vaccine should be avoided by: Severe allergic reaction to a previous dose or any vaccine component. Always inform your healthcare provider of your full medical history before vaccination.

The PCV – Pneumococcal Conjugate Vaccine typically costs ₹1,800 – ₹4,500 in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.